NEW YORK, Jan 4, 2026, 5:35 PM ET — Market closed
- Rocket Lab shares surged 8.9% on Friday, ending at $75.99.
- A late-day SEC Form 144 showed COO Frank Klein plans to sell up to 100,000 shares under a 10b5-1 plan.
- Focus turns to timing of Neutron milestones and the company’s next earnings update.
Rocket Lab Corp shares closed up 8.9% on Friday at $75.99, even as a regulatory filing showed the company’s chief operating officer has lined up a potential sale of stock.
The filing matters because Rocket Lab’s rally has pushed the stock toward its recent highs, leaving traders sensitive to any sign insiders are cashing out. A Form 144 is a required notice when an insider intends to sell restricted or control securities, and it can draw scrutiny even when it is procedural.
Klein’s notice also referenced a Rule 10b5-1 plan, a pre-arranged trading program that can allow executives to sell shares on a set schedule and help reduce the perception they are trading on nonpublic information.
The Form 144 filed on Jan. 2 listed up to 100,000 Rocket Lab common shares with an aggregate market value of about $6.98 million and named Morgan Stanley Smith Barney as the broker. The filing said the shares to be sold were acquired through the vesting of restricted stock units, and it was signed by Klein.
Rocket Lab traded between $66.85 and $76.24 on Friday after opening at $70.63, according to historical pricing data. The stock’s move came on volume of about 31.4 million shares.
Some investors have tied the broader bid for space and defense-linked names to Rocket Lab’s expanding role in U.S. national security satellite work. In December, the U.S. Space Development Agency placed a $3.5 billion order for 72 satellites, and Reuters reported Rocket Lab was among the companies signing fixed-price contracts for 18 space vehicles each.
Rocket Lab’s operational tempo has also been a talking point. In a Jan. 2 PRNewswire release, CEO Sir Peter Beck said the company planned to broaden Electron’s cadence and reach this year, pointing to “more multi-launch constellation deployments” and missions tied to civil and defense demand. PR Newswire
Analyst chatter has stayed active after the run. MarketBeat reported that research platform Wall Street Zen lifted its Rocket Lab rating to “hold” from “sell,” while also listing the stock’s 12-month high near $79.83 and a 50-day moving average around $56—one common gauge traders use to judge trend strength. MarketBeat
A key risk is that the stock’s momentum fades as investors reassess valuation against execution, especially with Rocket Lab still loss-making. In its most recent quarterly update, Rocket Lab posted record revenue of $155.08 million and guided for fourth-quarter 2025 revenue of $170 million to $180 million.
Next up is the company’s next earnings release and any refreshed timeline on larger-rocket milestones. Nasdaq’s calendar currently estimates Rocket Lab will report results on Feb. 26, though the company has not confirmed a date, and other tracking services show a late-February window.
